Restless Legs Syndrome in Patients with Epilepsy Under Levetiracetam Monotherapy

Journal Title: Türk Uyku Tıbbı Dergisi - Year 2018, Vol 5, Issue 1

Abstract

Objective: Restless Legs syndrome (RLS) is a frequent neurological disease. Levetiracetam (LEV) is an effective and broad-spectrum anticonvulsant drug. The aim of this study is to investigate the frequency of RLS in patients diagnosed with epilepsy who took LEV monotherapy. Materials and Methods: Two neurologists were reviewed the files of 1680 patients, who were followed in epilepsy outpatient clinic. One hundred seven patients under LEV monotherapy for at least six months and 120 healthy controls were included in the study. The criteria for the International Restless Legs Syndrome Study Group were taken into consideration for the assessment of RLS. Results: The mean age of patient group was 38.26±17.39 years, while the mean age of healthy controls was 39.17±16.12 years. There were no statistically significant differences in terms of age and sex between each two groups. The mean duration of LEV usage was 28.34 months. The LEV usage dose was between 500-3000 mg/day. RLS was seen in 7 (5.83%) healthy controls, whereas 4 patients (3.73%) had RLS in patient group before LEV treatment. The symptom of RLS in two patients disappeared after LEV treatment started and this rate decreased to 1.87%. The biochemical parameters were normal in all patient groups, after LEV treatment, peripheral neuropathy was detected in one patient whose symptoms were not relieved. Conclusion: LEV may have therapeutic effect on RLS. It may be preferred especially in comorbid situations where epilepsy and RLS are seen together. Longitudinal and prospective studies are needed to manifest better the therapeutic effects of LEV on RLS.

Authors and Affiliations

Gülnihal Kutlu, Fatma Genç, Yasemin Ünal, Dilek Aslan Öztürk, Abidin Erdal

Keywords

Related Articles

Evaluation of Sleep and Television Viewing Habits of Primary School Students

Objective: Sleep is crucial for healthy growth and development of children. Unsuitable television viewing habits are one of the important factors that disturb sleep patterns. This study was conducted to evaluate the slee...

Restless Legs Syndrome Treatments in Adults: Practice Guideline Summary of American Academy of Neurology

Restless legs syndrome is a common neurological disorder characterized by intense restlessness, relaxed with action, disturbance in the limbs and unpleasant sensations. Treatment should be considered if restless legs syn...

Mothers’ Preferences for Safe Sleep in Newborns

Objective: It is extremely important to provide safe sleep for babies to be protected from sudden infant death syndrome. The aim of this study is to determine the preferences of newborn mothers to sleep their babies. Mat...

The Role of 13 Years Insomnia on Physiological Variables of an Active Man: A Case Report

The aim of this study was to monitor role of insomnia on some physiological variables in a man who had 13 years insomnia. In this case report, we had a case with 27 years old, 64 kg body mass index, 167 cm height and 13...

The Relationship of Stroke and Sleep-A Review

Ischemic stroke appears the third leading cause of mortality and the first cause of disability in developing countries. The relationship between sleep disorders and cerebrovascular risk factors is well defined and there...

Download PDF file
  • EP ID EP368897
  • DOI 10.4274/jtsm.69188
  • Views 165
  • Downloads 0

How To Cite

Gülnihal Kutlu, Fatma Genç, Yasemin Ünal, Dilek Aslan Öztürk, Abidin Erdal (2018). Restless Legs Syndrome in Patients with Epilepsy Under Levetiracetam Monotherapy. Türk Uyku Tıbbı Dergisi, 5(1), 12-16. https://europub.co.uk/articles/-A-368897